Maryia Zhdanava

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 17

Top Topics

Top Venues

Applied health economics and health policy

Journal of medical economics

Drugs - real world outcomes

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States. Drugs - real world outcomes 11 (2) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy (2024)
Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States. Drugs - real world outcomes 11 (2) (2024)
Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States. Drugs - real world outcomes 11 (2) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States. Drugs - real world outcomes (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics (2023)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics 26 (1) (2023)
Kruti Joshi, Dominic Pilon, Aditi Shah, Christopher Holiday, Swapna Karkare, Maryia Zhdanava
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on Esketamine intranasal spray and covered by US commercial health plans. Journal of medical economics (2023)
Maryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, Sumesh Kachroo, Patrick Lefebvre, Dominic Pilon
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States. Crohn's & colitis 360 5 (3) (2023)
Kruti Joshi, Dominic Pilon, Aditi Shah, Christopher Holiday, Swapna Karkare, Maryia Zhdanava
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans. Journal of medical economics 26 (1) (2023)
Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R Feldman
Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy (2023)
Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R Feldman
Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA. Dermatology and therapy (2023)
Maryia Zhdanava, Amanda Teeple, Dominic Pilon, Aditi Shah, Gabrielle Caron-Lapointe, Kruti Joshi
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. Journal of medical economics 26 (1) (2023)